X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1062) 1062
Book Review (173) 173
Publication (71) 71
Conference Proceeding (51) 51
Book Chapter (12) 12
Book / eBook (3) 3
Web Resource (2) 2
Presentation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (637) 637
humans (619) 619
oncology (417) 417
female (385) 385
aged (349) 349
middle aged (342) 342
hematology (314) 314
male (314) 314
adult (266) 266
multiple myeloma (240) 240
antineoplastic combined chemotherapy protocols - therapeutic use (211) 211
multiple myeloma - drug therapy (181) 181
treatment outcome (181) 181
aged, 80 and over (180) 180
prognosis (153) 153
chemotherapy (149) 149
cancer (148) 148
bortezomib (146) 146
survival (128) 128
dexamethasone (101) 101
therapy (94) 94
antineoplastic combined chemotherapy protocols - adverse effects (93) 93
hematology, oncology and palliative medicine (91) 91
antineoplastic agents - therapeutic use (90) 90
abridged index medicus (89) 89
survival analysis (85) 85
lenalidomide (82) 82
care and treatment (79) 79
multiple myeloma - mortality (78) 78
stem-cell transplantation (75) 75
thalidomide - analogs & derivatives (73) 73
dexamethasone - administration & dosage (71) 71
disease-free survival (71) 71
multiple myeloma - pathology (71) 71
multiple-myeloma (67) 67
neoplasm staging (67) 67
recurrence (65) 65
survival rate (65) 65
thalidomide (65) 65
retrospective studies (59) 59
drug therapy (56) 56
risk factors (56) 56
multiple myeloma - therapy (55) 55
analysis (54) 54
multiple myeloma - complications (54) 54
multiple myeloma - diagnosis (54) 54
thalidomide - administration & dosage (53) 53
follow-up studies (52) 52
medical colleges (51) 51
combination (50) 50
disease progression (47) 47
diagnosis (46) 46
antineoplastic combined chemotherapy protocols - administration & dosage (44) 44
research (44) 44
patients (43) 43
rituximab (42) 42
kaplan-meier estimate (41) 41
cyclophosphamide (40) 40
drug administration schedule (40) 40
time factors (40) 40
trial (39) 39
breast cancer (38) 38
clinical trials (38) 38
risk (38) 38
combined modality therapy (37) 37
myeloma (37) 37
antineoplastic agents - adverse effects (36) 36
carcinoma (36) 36
medicine & public health (36) 36
paclitaxel (36) 36
prospective studies (36) 36
health aspects (35) 35
waldenstrom macroglobulinemia - drug therapy (35) 35
disease (34) 34
medical research (34) 34
neoplasm recurrence, local - drug therapy (34) 34
thalidomide - therapeutic use (34) 34
cisplatin (33) 33
transplantation (33) 33
carfilzomib (32) 32
monoclonal gammopathy (32) 32
ovarian cancer (32) 32
lymphoma (31) 31
open-label (31) 31
patient outcomes (31) 31
phase-ii trial (31) 31
plus dexamethasone (31) 31
thalidomide - adverse effects (31) 31
further section · weitere sektionen (30) 30
peripheral neuropathy (30) 30
relapse (30) 30
boronic acids - therapeutic use (29) 29
carboplatin (29) 29
pyrazines - therapeutic use (29) 29
remission induction (29) 29
salvage therapy (29) 29
boronic acids - administration & dosage (28) 28
dexamethasone - therapeutic use (28) 28
elderly-patients (28) 28
medicine, general & internal (28) 28
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Mayo Clinic Proceedings, ISSN 0025-6196, 03/2019, Volume 94, Issue 3, pp. 394 - 396
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 1, pp. 27 - 38
Journal Article
Journal Article
The Lancet Oncology, ISSN 1470-2045, 03/2018, Volume 19, Issue 3, pp. 277 - 278
Journal Article
The Lancet Oncology, ISSN 1470-2045, 01/2018, Volume 19, Issue 1, pp. e2 - e2
Journal Article
New England Journal of Medicine, ISSN 0028-4793, 06/2018, Volume 378, Issue 25, pp. 2399 - 2410
Journal Article
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 18, Issue 2, pp. 241 - 250
Journal Article
The Lancet Oncology, ISSN 1470-2045, 10/2017, Volume 18, Issue 10, pp. 1327 - 1337
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 12/2005, Volume 23, Issue 34, pp. 8580 - 8587
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 06/2013, Volume 31, Issue 18, pp. 2347 - 2357
Purpose The aim of the International Myeloma Working Group was to develop practice recommendations for the management of multiple myeloma (MM) -related bone... 
ZOLEDRONIC ACID | ONCOLOGY | VERTEBRAL AUGMENTATION | SKELETAL-RELATED EVENTS | UNDETERMINED SIGNIFICANCE | DOUBLE-BLIND | MONOCLONAL GAMMOPATHY | RANDOMIZED CONTROLLED-TRIAL | CLINIC CONSENSUS STATEMENT | SPINAL-CORD COMPRESSION | VITAMIN-D DEFICIENCY | Outcome Assessment (Health Care) - methods | Humans | Imidazoles - administration & dosage | Tomography, X-Ray Computed | Positron-Emission Tomography | Fractures, Bone - diagnosis | Medical Oncology - organization & administration | Multiple Myeloma - drug therapy | Bone Diseases - drug therapy | Diphosphonates - therapeutic use | Imidazoles - therapeutic use | Drug Therapy, Combination | Osteonecrosis - diagnosis | Bone Diseases - complications | Multiple Myeloma - complications | Bone Density Conservation Agents - therapeutic use | Bone Diseases - radiotherapy | Combined Modality Therapy | Diphosphonates - administration & dosage | International Cooperation | Bone Density Conservation Agents - administration & dosage | Magnetic Resonance Imaging | Administration, Intravenous | Radiotherapy - methods | Clodronic Acid - therapeutic use | Clodronic Acid - administration & dosage | Multiple Myeloma - radiotherapy | Osteonecrosis - prevention & control | Fractures, Bone - prevention & control | Practice Guidelines as Topic | Index Medicus | Hema20 | Gdln2 | Bone5 | Special | Hema23 | Hema22 | Hema21
Journal Article